Post-Marketing Surveillance (PMS) Study to Evaluate Safety and Efficacy of Zeldox Capsule
Latest Information Update: 04 Mar 2021
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders; Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer; Viatris Inc
- 03 Mar 2010 Actual patient number (21) added as reported by ClinicalTrials.gov.
- 03 Mar 2010 Actual end date (February 2010) added as reported by ClinicalTrials.gov.
- 03 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.